Crossmark

Botulinum toxin therapy: past, present and future developments

Crossref DOI link: https://doi.org/10.1007/s00702-022-02494-5

Published Online: 2022-04-09

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dressler, Dirk https://orcid.org/0000-0002-3612-3796
Johnson, Eric A.
Funding

Funding for this research was provided by:

Medizinische Hochschule Hannover (MHH)
License Information

Text and Data Mining valid from 2022-04-09

Version of Record valid from 2022-04-09
More Information

Article History

Received: 21 February 2022

Accepted: 23 March 2022

First Online: 9 April 2022